UnityPoint Health–St. Luke’s Hospital has become the first hospital in Cedar Rapids to offer a newly approved implantable ...
It felt like something inside me wound up and sucker-punched me from the inside out. The air around me got heavy.
New research finds that many of those who have received an implanted cardiac device to extend their life also have mood disorders, including anxiety, depression and PTSD. "Implantable cardioverter ...
NEW YORK (Reuters Health) - A common implantable device that helps stop dangerous heart rhythms by sending out small jolts of electricity sometimes misfires, Dutch researchers warn. Over 5 years, they ...
The S-ICD system with no leads in the heart When Boston Scientific announced its acquisition of Cameron Health in early 2012, it proclaimed that Cameron's subcutaneous ICD device with no leads in the ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can prevent arrhythmic death for people with congenital ...
WAUKESHA, Wis. - It’s a prescribed device that a doctor told a Waukesha man could save his life. Yet, his insurance provider has denied coverage, calling the device "not medically necessary." After ...
The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis. For patients with transthyretin cardiac ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
The major trials that established cardiac resynchronization therapy (CRT) as a treatment for heart failure (HF) with reduced ejection fraction (HFrEF) tended not to include patients who already had ...